Company Presentation

Azafaros B.V.

Country:The Netherlands/Switzerland
Category:Clinical Stage Biotech Company
Time:15:30 – 15:45
Speaker:Dr Stefano Portolano, CEO

Company profile

Azafaros is a clinical-stage biotech company addressing rare genetic lysosomal storage disorders with oral small molecules, including our lead asset, nizubaglustat. Our focus is on developing disease-modifying therapies for patients with GM1 and GM2 gangliosidoses, and Niemann-Pick Disease Type C.

Follow us